FDA Grants Psilocybin Second Ever Designation As Breakthrough Therapy Drug
This time last year, the FDA was designating psilocybin as a breakthrough therapy for depression for the very first time. “It really does represent a significant development in the whole history psychedelic research,” said Charles Grob at the time, psychiatry and behavioral sciences pressor at University California, Los Angeles. Now, the FDA …